Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Atezolizumab.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Atezolizumab.
Anthrax immune globulin, human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Atezolizumab.
Advertisement
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Atezolizumab.
BCG, Live, Connaught Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Atezolizumab.
BCG, Live, Tice Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Atezolizumab.
Advertisement
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Atezolizumab.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Atezolizumab.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Atezolizumab.
Advertisement
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Atezolizumab.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Atezolizumab.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Atezolizumab.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Atezolizumab.
Digoxin
Digoxin may decrease the cardiotoxic activities of Atezolizumab.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Atezolizumab.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Atezolizumab.
Hepatitis A Vaccine, Inactivated
The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Atezolizumab.
Hepatitis B Surface Antigen Vaccine
The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Atezolizumab.
Ouabain
Ouabain may decrease the cardiotoxic activities of Atezolizumab.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Atezolizumab.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Atezolizumab.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Atezolizumab.
Rabies Immune Globulin, Human
The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Atezolizumab.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Atezolizumab.
ROTAVIRUS VACCINE, LIVE
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Atezolizumab.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Atezolizumab.
Salmonella enterica subsp. enterica serovar typhi
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Atezolizumab.
Tetanus Toxoid Vaccine, Inactivated
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Atezolizumab.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Atezolizumab.
Typhoid Vaccine Live Ty21a
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Atezolizumab.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The therapeutic efficacy of Salmonella typhi ty2 vi polysaccharide antigen can be decreased when used in combination with Atezolizumab.
Varicella Virus Vaccine Live (Oka-Merck) strain
The therapeutic efficacy of Varicella Zoster Vaccine (Live/Attenuated) can be decreased when used in combination with Atezolizumab.
Yellow Fever Vaccine
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Atezolizumab.
Yellow-Fever Virus Vaccine, 17D-204 strain
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Atezolizumab.
